Monday, 1 June 2015

Immune-Based Drug Shows Potential Against Another Form of Lung Cancer

Findings suggest lung cancer develops through

Patients with squamous cell non-small cell lung cancer who got nivolumab lived longer, had fewer side effects



from WebMD Health http://ift.tt/1KI1x6P

No comments:

Post a Comment